ReviewJournal of evaluation in clinical practice2025
Evidence-Based Approaches to Quality Improvement: A Narrative Review of Integrating Bayesian Adaptive Trials Into Health Services.
Review in Journal of evaluation in clinical practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Importance and Potential of Rare Disease Research in Pediatric Rheumatology and Beyond: Pushing Frontiers.ACR open rheumatology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
rationaleQuality improvement (QI) in health service programmes aims to make small, incremental changes to increase reach and efficiency. Simple, low-risk programmatic changes can improve services, particularly when supported by robust evidence. However, in health service contexts, there is tension between the need for swift decision-making and the high research standards for conducting methodologically rigorous trials. Randomized trials are rarely used to evaluate these changes due to high costs and long timelines, especially when the changes are expected to result in marginal improvements. Instead, health service programmes frequently introduce changes informed by anecdotal evidence or less robust evaluation methods such as before-and-after comparisons.
aimsIn this paper, we present a narrative review of the concepts underlying Bayesian adaptive trial designs for conducting QI research, highlighting their use in the commercial sector and exploring opportunities for cross-industry learning and future application in healthcare settings.
methodsRelevant studies were selected based on their contextual relevance to the topic, in keeping with the narrative review approach.
resultsGiven that programmatic changes typically yield modest improvements, we recommend that adaptive trial designs can strike a balance between obtaining reliable results and avoiding overly large sample sizes. We review how interim analysis and early stopping can be integrated into trials, allowing the level of rigour to be adjusted according to the proramme specifications.
conclusionAdaptive trial designs hold significant promise for enhancing the QI efforts. To ensure that adaptive trial designs can be successfully integrated into health service contexts, tradeoffs should be made between methodological rigour and resource constraints.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.